IFP Advisors’s Intersect ENT, Inc XENT Stock Holding History

IFP Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$1.81K	–	3065
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	2664
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	2671
2019 Q4	$2K	Hold	100	–	–	﹤0.01%	2571
2019 Q3	$2K	Buy	+100	New	+$1.82K	﹤0.01%	2759
2017 Q4	–	Sell	-120	Closed	-$4K	–	4200
2017 Q3	$4K	Buy	+120	New	+$3.55K	﹤0.01%	3559
2016 Q3	–	Sell	-500	Closed	-$6K	–	4105
2016 Q2	$6K	Buy	+500	New	+$7.83K	﹤0.01%	3080

Other funds holding XENT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

IFP Advisors's XENT Position: Q3 2020 in Review

IFP Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 100 shares — an estimated $1.81K sold.

IFP Advisors first reported a position in XENT in Q2 2016 and held it in 6 quarters. The position peaked at $6K in Q2 2016. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

IFP Advisors reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
IFP Advisors sold 100 Intersect ENT, Inc shares in Q3 2020, an estimated $1.81K.
IFP Advisors first reported a position in Intersect ENT, Inc in Q2 2016 and held it in 6 quarters.
IFP Advisors's Intersect ENT, Inc position peaked at $6K in Q2 2016.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on IFP Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.